RYVYL Reports Q3 2024 Results
| September 30, 2024 | December 31, 2023 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 4,263 | $ | 12,180 | ||||
| Restricted cash | 87,220 | 61,138 | ||||||
| Accounts receivable, net of allowance for credit losses of $152 and $23, respectively | 851 | 859 | ||||||
| Cash due from gateways, net of allowance of $125 and $2,636, respectively | 66 | 12,834 | ||||||
| Prepaid and other current assets | 3,313 | 2,854 | ||||||
| Total current assets | 95,713 | 89,865 | ||||||
| Non-current Assets: | ||||||||
| Property and equipment, net | 1,300 | 306 | ||||||
| Goodwill | 20,318 | 26,753 | ||||||
| Intangible assets, net | 3,676 | 5,059 | ||||||
| Operating lease right-of-use assets, net | 3,627 | 4,279 | ||||||
| Other assets | 2,677 | 2,403 | ||||||
| Total non-current assets | 31,598 | 38,800 | ||||||
| Total assets | $ | 127,311 | $ | 128,665 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable | $ | 2,986 | $ | 1,819 | ||||
| Accrued liabilities | 7,569 | 5,755 | ||||||
| Payment processing liabilities, net | 87,542 | 76,772 | ||||||
| Current portion of operating lease liabilities | 821 | 692 | ||||||
| Other current liabilities | 1,220 | 504 | ||||||
| Total current liabilities | 100,138 | 85,542 | ||||||
| Long term debt, net of debt discount | 17,706 | 15,912 | ||||||
| Operating lease liabilities, less current portion | 3,144 | 3,720 | ||||||
| Total liabilities | 120,988 | 105,174 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders' Equity: | ||||||||
| Preferred stock, Series B, par value $0.01, 5,000,000 shares authorized; shares issued and outstanding 53,950 and 55,000 at September 30, 2024 and December 31, 2023, respectively | 1 | 1 | ||||||
| Common stock, par value $0.001, 100,000,000 shares authorized, shares issued and outstanding of 6,957,875 and 5,996,948 at September 30, 2024 and December 31, 2023, respectively | 7 | 6 | ||||||
| Additional paid-in capital | 177,750 | 175,664 | ||||||
| Accumulated other comprehensive income | 1,120 | 401 | ||||||
| Accumulated deficit | (172,555 | ) | (152,581 | ) | ||||
| Total stockholders' equity | 6,323 | 23,491 | ||||||
| Total liabilities and stockholders ' equity | $ | 127,311 | $ | 128,665 |
RYVYL INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(Dollars in thousands, except share and per share data)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Revenue | $ | 12,606 | $ | 17,480 | $ | 41,280 | $ | 43,620 | ||||||||
| Cost of revenue | 7,749 | 10,800 | 24,643 | 25,703 | ||||||||||||
| Gross profit | 4,857 | 6,680 | 16,637 | 17,917 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Advertising and marketing | 42 | 45 | 74 | 153 | ||||||||||||
| Research and development | 815 | 1,315 | 3,027 | 4,434 | ||||||||||||
| General and administrative | 1,442 | 3,041 | 5,107 | 6,709 | ||||||||||||
| Payroll and payroll taxes | 3,251 | 2,605 | 9,670 | 8,232 | ||||||||||||
| Professional fees | 1,061 | 1,234 | 3,356 | 5,651 | ||||||||||||
| Stock compensation expense | 136 | 147 | 542 | 309 | ||||||||||||
| Depreciation and amortization | 590 | 657 | 1,826 | 1,899 | ||||||||||||
| Impairment of goodwill | - | - | 6,675 | - | ||||||||||||
| Restructuring charges | - | - | 1,636 | - | ||||||||||||
| Total operating expenses | 7,337 | 9,044 | 31,913 | 27,387 | ||||||||||||
| Loss from operations | (2,480 | ) | (2,364 | ) | (15,276 | ) | (9,470 | ) | ||||||||
| Other income (expense): | ||||||||||||||||
| Interest expense | (309 | ) | (65 | ) | (462 | ) | (3,310 | ) | ||||||||
| Accretion of debt discount | (273 | ) | (4,183 | ) | (1,978 | ) | (9,626 | ) | ||||||||
| Changes in fair value of derivative liability | - | 6,909 | 14 | 6,580 | ||||||||||||
| Derecognition expense on conversion of convertible debt | - | (1,331 | ) | (68 | ) | (1,518 | ) | |||||||||
| Legal settlement expense | (1,598 | ) | (1,929 | ) | (1,598 | ) | (4,142 | ) | ||||||||
| Other income (expense) | 72 | (25 | ) | 608 | (1,474 | ) | ||||||||||
| Total other income (expense), net | (2,108 | ) | (624 | ) | (3,484 | ) | (13,490 | ) | ||||||||
| Loss before provision for income taxes | (4,588 | ) | (2,988 | ) | (18,760 | ) | (22,960 | ) | ||||||||
| Income tax provision | 586 | 128 | 1,214 | 138 | ||||||||||||
| Net loss | $ | (5,174 | ) | $ | (3,116 | ) | $ | (19,974 | ) | $ | (23,098 | ) | ||||
| Comprehensive income statement: | ||||||||||||||||
| Net loss | (5,174 | ) | (3,116 | ) | (19,974 | ) | (23,098 | ) | ||||||||
| Foreign currency translation gain (loss) | 1,338 | (317 | ) | 719 | (389 | ) | ||||||||||
| Total comprehensive loss | $ | (3,836 | ) | $ | (3,433 | ) | $ | (19,255 | ) | $ | (23,487 | ) | ||||
| Net loss per share: | ||||||||||||||||
| Basic and diluted | $ | (0.76 | ) | $ | (0.60 | ) | $ | (3.12 | ) | $ | (4.48 | ) | ||||
| Weighted average number of common shares outstanding: | ||||||||||||||||
| Basic and diluted | 6,812,248 | 5,231,588 | 6,408,993 | 5,160,499 |
RYVYL INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
| Nine Months Ended September 30, | ||||||||
| 2024 | 2023 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (19,974 | ) | $ | (23,098 | ) | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
| Depreciation and amortization expense | 1,826 | 1,899 | ||||||
| Noncash lease expense | 205 | 246 | ||||||
| Stock compensation expense | 542 | 309 | ||||||
| Accretion of debt discount | 1,978 | 9,626 | ||||||
| Derecognition expense upon conversion of convertible debt | 68 | 1,518 | ||||||
| Changes in fair value of derivative liability | (14 | ) | (6,580 | ) | ||||
| Impairment of goodwill | 6,675 | - | ||||||
| Restructuring charges | 1,636 | - | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable, net | 70 | 457 | ||||||
| Prepaid and other current assets | (460 | ) | 6,841 | |||||
| Cash due from gateways, net | 12,706 | (896 | ) | |||||
| Other assets | (318 | ) | (1,480 | ) | ||||
| Accounts payable | 1,166 | 1,962 | ||||||
| Accrued and other current liabilities | 1,943 | 1,333 | ||||||
| Accrued interest | 300 | 554 | ||||||
| Payment processing liabilities, net | 10,770 | 34,893 | ||||||
| Net cash provided by operating activities | $ | 19,119 | $ | 27,584 | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of property and equipment | (34 | ) | (78 | ) | ||||
| Capitalized software development costs | (1,100 | ) | - | |||||
| Purchase of intangible assets | (93 | ) | - | |||||
| Net cash used in investing activities | (1,226 | ) | (78 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Repayments on long term debt | (13 | ) | (11 | ) | ||||
| Treasury stock purchases | (194 | ) | - | |||||
| Net cash used in financing activities | (207 | ) | (11 | ) | ||||
| Effects of exchange rates on cash, cash equivalents, and restricted cash | 479 | 26 | ||||||
| Net increase in cash, cash equivalents, and restricted cash | 18,165 | 27,521 | ||||||
| Cash, cash equivalents, and restricted cash – beginning of period | 73,318 | 40,834 | ||||||
| Cash, cash equivalents, and restricted cash – end of period | $ | 91,483 | $ | 68,355 | ||||
| Supplemental disclosures of cash flow information | ||||||||
| Cash paid during the period for: | ||||||||
| Interest | $ | - | $ | 2,709 | ||||
| Income taxes | $ | 759 | $ | - | ||||
| Non-cash financing and investing activities: | ||||||||
| Convertible debt conversion to common stock | $ | 200 | $ | 300 | ||||
| Convertible debt conversion to preferred stock | $ | - | $ | 4,297 | ||||
| Interest accrual from convertible debt converted to preferred stock | $ | - | $ | 2,271 | ||||
| Interest accrual from convertible debt converted to common stock | $ | - | $ | 3 |
Use of Non-GAAP Financial Information
Adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”) is a non-GAAP measure that represents our net loss before interest expense, amortization of debt discount, income tax expense, depreciation and amortization, changes in the fair value of derivative liabilities, losses on the extinguishment and derecognition expenses on the conversion of convertible debt, non-cash stock-based compensation expense, acquisition-related expense, non-recurring provisions for credit losses on legacy matters, accounting fees related to the restatement of prior period financial statements, non-recurring costs related to the spin-off of a subsidiary, and legal costs and settlement fees incurred in connection with non-ordinary course litigation and other disputes.
We exclude these items in calculating Adjusted EBITDA because we believe that the exclusion of these items will provide for more meaningful information about our financial performance, and do not consider the excluded items to be part of our ongoing results of operations. Our use of Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our financial results as reported under GAAP. Some of these limitations are: (a) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements; (b) Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; (c) Adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; (d) Adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us; and (e) other companies, including companies in our industry, may calculate Adjusted EBITDA or similarly titled measures differently, which reduces its usefulness as a comparative measure.
Because of these and other limitations, you should consider Adjusted EBITDA alongside our other GAAP-based financial performance measures, net income (loss) and our other GAAP financial results. The following table presents a reconciliation of Adjusted EBITDA from net loss, the most directly comparable GAAP measure, for the periods indicated:
Reconciliation of Net Loss attributable to RYVYL, Inc., to Adjusted EBITDA for the
Three and Nine Months Ended September 30, 2024 and 2023
(in thousands, except share and per share data)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Net loss | $ | (5,174 | ) | $ | (3,116 | ) | $ | (19,974 | ) | $ | (23,098 | ) | ||||
| Interest expense | 309 | 65 | 462 | 3,310 | ||||||||||||
| Accretion of debt discount | 273 | 4,183 | 1,978 | 9,626 | ||||||||||||
| Income tax provision | 586 | 128 | 1,214 | 138 | ||||||||||||
| Depreciation and amortization | 590 | 657 | 1,826 | 1,899 | ||||||||||||
| EBITDA | (3,416 | ) | 1,917 | (14,494 | ) | (8,125 | ) | |||||||||
| Other non-cash adjustments: | ||||||||||||||||
| Changes in fair value of derivative liability | - | (6,909 | ) | (14 | ) | (6,580 | ) | |||||||||
| Derecognition expense on conversion of convertible debt | - | 1,331 | 68 | 1,518 | ||||||||||||
| Stock compensation expense | 136 | 147 | 542 | 309 | ||||||||||||
| Impairment of goodwill | - | - | 6,675 | - | ||||||||||||
| Restructuring charges | - | - | 1,636 | - | ||||||||||||
| Special items: | ||||||||||||||||
| Non-recurring legal settlements and ongoing matters and related legal fees | 1,598 | 2,197 | 1,598 | 5,308 | ||||||||||||
| Carryover effects of financial statement restatements in prior periods | - | - | - | 1,222 | ||||||||||||
| Non-recurring provision for credit losses on legacy matters | 1,369 | 1,994 | ||||||||||||||
| Accounting fees related to the restatement of prior period financial statements | - | - | - | 237 | ||||||||||||
| Non-recurring impairment of right of use asset | - | - | - | 100 | ||||||||||||
| Non-recurring costs of spin-off | - | - | - | 29 | ||||||||||||
| Adjusted EBITDA | $ | (1,682 | ) | $ | 52 | $ | (3,989 | ) | $ | (3,988 | ) | |||||
| Loss from operations | $ | 2,480 | ) | $ | (2,364 | ) | $ | (15,276 | ) | $ | (9,470 | ) |

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment